News & Events > News > MSK, NYGC Collaborat...

MSK, NYGC Collaborative Study Pinpoints New Cause of Resistance to EGFR-Targeting Drugs

June 7, 2018

The image at right shows cells taken from a person with lung cancer and labeled with fluorescent probes (a technique called FISH). The red probe is specific for the YES1 gene. The green probe recognizes a part of chromosome 18 where YES1 is usually found. Cells with extra copies of the YES1 gene have significantly more red spots than green spots. Image courtesy Lu Wang.

A collaborative study between scientists at Memorial Sloan Kettering Cancer Center and the New York Genome Center has identified one way that lung cancer cells outsmart a common targeted drug therapy. The results, reported June 6, 2018 in the Proceedings of the National Academy of Sciences, pave the way for improved treatments.

Read the June 7 MSK blog story

Back to All News Next News Post
Decorative image color fade left Decorative image color fade right Decorative image color fade